Researchers demonstrate new multispectral microscope to speed up drug discovery

A new multispectral microscope, one capable of processing nearly 17 billion pixels representing 13 individual color channels in a single image, has been successfully demonstrated by a team of researchers from the United States and Australia. This is the largest such microscopic image ever created. This level of multicolor detail is essential for studying the impact of experimental drugs on biological samples and is an important advancement over traditional microscope designs, which have fallen short when it comes to imaging large, spectrally diverse samples.

The power of this innovative instrument is to simultaneously process large amounts of data, thus addressing a major bottleneck in pharmaceutical research: rapid, data-rich biomedical imaging.

By merging data simultaneously collected by thousands of microlenses - optical elements each smaller than the width of a human hair - this new multispectral microscope is able to produce a continuous series of datasets that essentially reveal how much of multiple colors are present at each point in a single biological sample.

"Pharmaceutical research is awash with cutting-edge equipment that tries to image what is happening at the cellular level and smaller," said Antony Orth, a researcher formerly at the Rowland Institute, Harvard University in Cambridge and now with the ARC Centre for Nanoscale BioPhotonics, RMIT University in Melbourne, Australia.

"We recognized that the microscopy part of the drug development pipeline was much slower than it could be and designed a system specifically for this task."

Orth and his colleagues published their results in Optica, the new high-impact journal of The Optical Society.

Multispectral Imaging - Color and Data Combine

Multispectral imaging is used for a variety of scientific and medical research applications. This process not only produces an image, it also provides data about specific colors, or frequencies, in that image. Medical researchers are able to study these frequencies to learn about the composition and chemical processes that are taking place within a biological sample. This is essential for pharmaceutical research - particularly cancer research -- to observe how cells and tissues respond to specific chemicals and experimental drugs.

Such research, however, is very data intensive and slow since current multispectral microscopes can only survey a single point at a time with few color channels, typically only 4 or 5. This process must then be repeated over and over to scan the entire sample.

Microlenses and Parallel Processing for Big Data

To overcome these limitations, Orth and his team took inspiration from modern computing, in which massive amounts of data and calculations are simultaneous handled by multicore processors. In the case of imaging, however, the work of a single microscope lens is distributed among an entire array or microlenses, each responsible for collecting multispectral data for a very narrow portion of each sample.

To capture this data, a laser is focused onto a small spot on the sample by each microlens. The laser light causes the sample to fluoresce, emitting specific wavelengths of light that differ depending on the molecules that are present. This fluorescence is then imaged back onto the camera. This is done for thousands of microlenses at once.

This multipoint scanning greatly reduces the amount of time necessary to image a sample by simultaneously harnessing thousands of lenses.

"By recording the color spectrum of the fluorescence, we can determine how much of each fluorescing molecule is in the sample," said Orth. "What makes our microscope particularly powerful is that it records many different colors at once, allowing researchers to highlight a large number of structures in a single experiment."

To demonstrate their design, the researchers applied various dyes that adhere to specific molecules within a cell sample. These dyes respond to laser light by fluorescing at specific frequencies so they can be detected and localized with high precision. Each microlens then looked at a very small part of the sample, an area about 0.6 by 0.1 millimeters in size. The raw data produced by this was a series of small images roughly 1,200 by 200 pixels wide.

These individual multicolor images were then stitched together into a large mosaic image. By simultaneously imaging 13 separate colors bands, the dataset produced was nearly 17 billion pixels in size.

In scientific imaging, such multilayered files are referred to as "datacubes," because they contain three dimensions - two spatial (the X and Y coordinates) and one dimension of color. "The dataset basically tells you how much of each color you have at any given X-Y position in the sample," explained Orth.

This design is a significant improvement over regular, single-lens microscopes, which take a series of medium-sized pictures in a serial fashion. Since they cannot see the entire sample at once, it's necessary to take one picture and then move the sample to capture the next. This means the sample has to remain still while the microscope is refocused or color filters are changed. Orth and his colleagues' design eliminates much of this mechanical dead-time and is almost always imaging.

The Challenge of Big Data

This novel approach initially presented a challenge in the data pipeline. The raw data is in the form of one megapixel images recorded at 200 frames per second - a data rate much higher than current microscopes, which required the team to capture and process a tremendous amount of data each second. Over time, the availability and prices of fast cameras and fast hard drives have come down considerably, allowing for a much more affordable and efficient design. The current limiting factor is loading the recorded data from hard drives to active computer memory to produce an image. The researchers estimate that an active memory of about 100 gigabytes to store the raw dataset would improve the entire process even further.

Impact of Big Data on Multispectral Imaging

The goal of this technology is to speed up drug discovery. For example, to study the impact of a new cancer drug it's essential to determine if a specific drug kills cancer cells more often than healthy cells. This requires testing the same drug on thousands to millions of cells with varying doses and under different conditions, which is normally a very time-consuming and labor-intensive task.

The new microscope presented in this paper speeds up this process while also looking at many different colors at once. "This is important because the more colors you can see, the more insightful and efficient your experiments become," noted Orth. "Because of this, the speed-up afforded by our microscope goes beyond just the improvement in raw data rate."

Continuing this research, the team would like to expand to live cell imaging in which billion-pixel, time-lapse movies of cells moving and responding to various stimuli could be made, opening the door to experiments that currently aren't possible with small-scale time-lapse movies.

"We have redesigned and revamped the boring old microscope to speed up cellular imaging, which will help researchers discover life-changing drugs more quickly and efficiently," concludes Orth.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New deep-learning framework identifies non-addictive pain relief options